Luo Yuling bought ALMR
April 20, 2026 · Form 4 insider transaction
Luo Yuling bought 1,224,152 shares of Alamar Biosciences, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,224,152
Price
N/A
Total value
N/A
InsiderLuo Yuling
RoleOfficer, Director
SecurityClass B Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateApril 20, 2026
Filing dateApril 20, 2026
Shares owned after1,224,152
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the "IPO").